Sachs Associates is a long-established international conference company that runs a limited number of high profile conferences focused on bio-pharma, medtech, and digital health. These conferences focus on licensing and investment opportunities and provide presenting opportunities for companies as well as partnering facilities for all delegates to network.
The final Sachs Associates conference of Q1 is The 5th Annual Neuroscience Innovation Forum (NIF) to be held digitally, on 22nd – 23rd March 2022 in the Eastern Daylight (EDT) Time Zone.
The target audience for this event are buy and sell-side analysts from investment banks and funds, as well as partnering executives from pharma, biotech, digital therapeutics and neurotech companies. Meetings will take place from the 21st – 25th of March, with the online meeting system being open for 12 hours a day.
As a supporter of Sachs Associates, Optimum is pleased to be able to offer a 10% discount on the below events for Q1 2022. Please email firstname.lastname@example.org to receive the code.
Additional Q1 Sachs Associate events to add to your calendar are;
28th February 2022 – 3rd Annual European HealthTech CEO Forum (EHTF)
22nd -23rd March 2022 – 5th Annual Neuroscience Innovation Forum (NIF)
3rd June 2022 – 8th Annual Immuno-Oncology Innovation Forum (IOIF)
20th September 2022 – 9th Annual HealthTech Investment Forum (HTIF)
21st – 22nd September – 22nd Annual Biotech in Europe Forum (BEF)